Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blot

World Journal of Urology
Renate PichlerAndrea Brunner

Abstract

To clarify the role of human papillomavirus (HPV) in non-muscle invasive bladder cancer, HPV-DNA was scrutinized in formalin-fixed, paraffin-embedded (FFPE) bladder cancer tissue using single-step PCR (HPV L1) for HPV detection, followed by reverse line blot (RLB) for genotyping. A total of 186 patients who underwent transurethral resection of the bladder due to primary, non-muscle invasive bladder cancer from 2006 to 2009 were reviewed. A positive control group of 22 cervical tissues with cervical carcinoma was included. Histology confirmed urothelial carcinoma in all patients: primary CIS, pTa, pT1 and pTa + pT1 in 14 (7.5 %), 134 (72 %), 36 (19.4 %) and two (1.1 %) patients, respectively. A total of 119 (63.9 %) of them were classified as low-risk, while 67 (36.1 %) were high-risk cancers. Tumor recurrence and progression (≥pT2) were seen in 79 and 11 patients (mean follow-up 45 months). The presence of HPV-DNA by single-step PCR was detected in four (2.2 %) patients. HPV 16 and HPV 6 were positive in two (1.1 %) and one (0.6 %) patient, respectively In one case, no HPV genotype listed on the RLB assay could be identified. In the control group, the HPV infection rate was 100 %: HPV 16 in 12 (54.6 %) patients, HPV 16/18 in fo...Continue Reading

References

Jan 1, 1996·British Journal of Cancer·A Lopez-BeltranJ C Carrasco
Jul 9, 1999·Journal of Clinical Pathology·C De GaetaniG P Trentini
Sep 13, 2001·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·S LaconiP Pani
Dec 13, 2003·Urologic Oncology·Hussein M KhaledNadia Mokhtar
Mar 13, 2008·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Andrea BrunnerAlexandar Tzankov
Dec 29, 2009·Cancer Letters·Victor E GouldPaolo Gattuso
Apr 30, 2010·Medical Oncology·Dilek YavuzerDilek Sakirahmet
Feb 18, 2011·Journal of Clinical Microbiology·Anke PierikAdriaan J C van den Brule
Apr 28, 2011·Cancer·Kazuyoshi ShigeharaMikio Namiki
Jun 16, 2011·The Journal of Infectious Diseases·Ni LiMin Dai
Jun 12, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Riley E AlexanderLiang Cheng
Sep 14, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Georgios I PanagiotakisDemetrios A Spandidos
Oct 22, 2013·Urologic Oncology·Yanis TolstovStefan Duensing
May 24, 2014·Nature Reviews. Cancer·Renske D M SteenbergenChris J L M Meijer

❮ Previous
Next ❯

Citations

Sep 9, 2017·Urologia·Ioannis KatafigiotisConstantinos Constantinides
Jan 29, 2020·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Kit Riegels Jørgensen, Jørgen Bjerggaard Jensen
Feb 9, 2017·Nature Reviews. Urology·Alexander P GlaserJoshua J Meeks
Sep 3, 2020·Infectious Agents and Cancer·Solmaz Ohadian MoghadamAli Nowroozi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

© 2021 Meta ULC. All rights reserved